Evidence map›Paper›PMID 9528786›Full record

ArticleMolecular and cellular biology1998

Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line.

E M Eves, W Xiong, A Bellacosa, S G Kennedy, P N Tsichlis, M R Rosner, N Hay

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 191 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Insulin and insulin-like growth factor resistance in alcoholic neurodegeneration.Alcoholism, clinical and experimental research · 2008
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

E M EvesBen May Institute for Cancer Research and Department of Pharmacological and Physiological Sciences, University of Chicago, Illinois 60637, USA. eeves@ben-may.bsd.uchicago.edu
W Xiong
A Bellacosa
S G Kennedy
P N Tsichlis
M R Rosner
N Hay
May Institute · USCancer Research Center · USFox Chase Cancer Center · USUniversity of Chicago · US

Funding

Akt in T cell development and functionR01CA057436 · NCI · TUFTS MEDICAL CENTER · PI TSICHLIS, PHILIP N. · 1994 to 2011
$3.2M
Signaling Pathways in Neuronal CellsR01NS033858 · NINDS · UNIVERSITY OF CHICAGO · PI ROSNER, MARSHA R · 1995 to 2007
$2.8M
C-MYC ONCOPROTEIN IN CELL CYCLE PROGRESSION/ APOPTOSISR01CA071874 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HAY, NISSIM · 1997 to 1999
–
NCI NIH HHS CA 57436NCI NIH HHS CA 71874NCI NIH HHS R01 CA057436NINDS NIH HHS NS 33858NINDS NIH HHS R01 NS033858
6 · The paper itself

Abstract

Phosphatidylinositol (PI) 3-kinase has been suggested to mediate cell survival. Consistent with this possibility, apoptosis of conditionally (simian virus 40 Tts) immortalized rat hippocampal H19-7 neuronal cells was increased in response to wortmannin, an inhibitor of PI 3-kinase. Downstream effectors of PI 3-kinase include Rac1, protein kinase C, and the serine-threonine kinase Akt (protein kinase B). Here, we show that activation of Akt is one mechanism by which PI 3-kinase can mediate survival of H19-7 cells during serum deprivation or differentiation. While ectopic expression of wild-type Akt (c-Akt) does not significantly enhance survival in H19-7 cells, expression of activated forms of Akt (v-Akt or myristoylated Akt) results in enhanced survival which can be comparable to that conferred by Bcl-2. Conversely, expression of a dominant-negative mutant of Akt accelerates cell death upon serum deprivation or differentiation. Finally, the results indicate that Akt can transduce a survival signal for differentiating neuronal cells through a mechanism that is independent of induction of Bcl-2 or Bcl-XL or inhibition of Jun kinase activity.

Indexed as

ApoptosisAndrostadienesAnimalsbcl-X ProteinCell DifferentiationCell LineCulture Media, Serum-FreeEnzyme ActivationEnzyme InhibitorsGenes, DominantMutationNeuronsOncogene Protein v-aktPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProtein Serine-Threonine KinasesAkt1 protein, ratAndrostadienesBcl2l1 protein, ratbcl-X ProteinCulture Media, Serum-FreeEnzyme InhibitorsOncogene Protein v-aktPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-bcl-2Retroviridae Proteins, OncogenicWortmannin

Identifiers

PMID9528786
PMCPMC121450
OpenAlexW1914067219

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.